Page 1209 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 1209

2      References


                   28. Sander HW, Golden M, Danon MJ. Quadriplegic areflexic ICU     47. Rossignol B, Gueret G, Pennec JP, et al. Effects of chronic sepsis
                      illness: selective thick filament loss and normal nerve histology.   on the voltage-gated sodium channel in isolated rat muscle
                      Muscle Nerve. 2002;26:499-505.                         fibers. Crit Care Med. 2007;35:351-357.
                   29. Puthucheary ZA, Rawal J, McPhail M, et al. Acute skeletal     48. Op de Coul AA, Verheul GA, Leyten AC, Schellens RL, Teepen
                      muscle wasting in critical illness. JAMA. 2013;310:1591-1600.  JL. Critical illness polyneuromyopathy after artificial respira-
                   30. Tillquist M, Leung R, Kutsogiannis DJ, et al. Bedside ultrasound   tion. Clin Neurol Neurosurg. 1991;93:27-33.
                      is a practical and reliable measurement tool for assessing quad-    49. Khan J, Harrison TB, Rich MM, Moss M. Early development of
                      riceps muscle layer thickness.  JPEN  J  Parenter  Enteral  Nutr.   critical illness myopathy and neuropathy in patients with severe
                      2014;38:886-890.                                       sepsis. Neurology. 2006;67:1421-1425.
                   31. Lacomis D. Electrophysiology of neuromuscular disorders in     50. Segredo V, Caldwell JE,  Matthay MA, Sharma  ML, Gruenke
                      critical illness. Muscle Nerve. 2013;47:452-463.       LD, Miller RD. Persistent paralysis in critically ill patients
                   32. Garnacho-Montero J, Amaya-Villar R, Garcia-Garmendia JL,   after long-term administration of vecuronium. N Engl J Med.
                      Madrazo-Osuna J, Ortiz-Leyba C. Effect of critical illness polyneu-  1992;327:524-528.
                      ropathy on the withdrawal from mechanical ventilation and the     51. Stevens RD, Dowdy DW, Michaels RK, Mendez-Tellez PA,
                      length of stay in septic patients. Crit Care Med. 2005;33:349-354.  Pronovost PJ, Needham DM. Neuromuscular dysfunction
                   33. Latronico N, Peli E, Botteri M. Critical illness myopathy and   acquired in critical illness: a systematic review. Intensive Care
                      neuropathy. Curr Opin Crit Care. 2005;11:126-132.      Med. 2007;33:1876-1891.
                   34. Witt NJ, Zochodne DW, Bolton CF, et al. Peripheral nerve func-    52. Hough CL, Steinberg KP, Taylor Thompson B, Rubenfeld GD,
                      tion in sepsis and multiple organ failure. Chest. 1991;99:176-184.  Hudson LD. Intensive care unit-acquired neuromyopathy and
                   35. Bolton CF, Young GB, Zochodne DW. The neurological compli-  corticosteroids in survivors of persistent ARDS. Intensive Care
                      cations of sepsis. Ann Neurol. 1993;33:94-100.         Med. 2009;35:63-68.
                   36. Koch  S,  Spuler  S,  Deja M,  et  al.  Critical  illness  myopathy  is     53. Leatherman  JW,  Fluegel  WL,  David WS,  Davies  SF,  Iber  C.
                      frequent: accompanying neuropathy protracts ICU discharge.     Muscle weakness in mechanically ventilated patients with
                      J Neurol Neurosurg Psychiatry. 2011;82:287-293.        severe asthma. Am J Respir Crit Care Med. 1996;153:1686-1690.
                   37. Douglass JA, Tuxen DV, Horne M, et al. Myopathy in severe     54. Behbehani  NA, Al-Mane  F, D’Yachkova Y, Pare  P, FitzGerald
                      asthma. Am Rev Respir Dis. 1992;146:517-519.           JM. Myopathy following mechanical ventilation for acute severe
                                                                             asthma: the role of muscle relaxants and corticosteroids. Chest.
                   38. Zochodne DW, Ramsay DA, Saly V, Shelley S, Moffatt S. Acute   1999;115:1627-1631.
                      necrotizing myopathy of intensive care: electrophysiological
                      studies. Muscle Nerve. 1994;17:285-292.             55. Hermans  G,  De  Jonghe  B,  Bruyninckx  F,  Van  den  Berghe  G.
                                                                             Interventions  for  preventing  critical  illness  polyneuropathy
                   39. Goodman BP, Harper CM, Boon AJ. Prolonged compound    and critical illness myopathy. Cochrane database of systematic
                      muscle  action  potential duration in  critical  illness  myopathy.   reviews (Online). 2009:CD006832.
                      Muscle Nerve. 2009;40:1040-1042.
                                                                          56. van den Berghe G, Wouters P, Weekers F, et al. Intensive
                   40. Road J, Mackie G, Jiang TX, Stewart H, Eisen A. Reversible   insulin therapy in the critically ill patients.  N  Engl  J  Med.
                      paralysis with status asthmaticus, steroids, and pancuronium:   2001;345:1359-1367.
                      clinical electrophysiological correlates. Muscle Nerve. 1997;20:
                      1587-1590.                                          57. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy
                                                                             and  pentastarch  resuscitation  in  severe  sepsis.  N Engl J Med.
                   41. Rouleau G, Karpati G, Carpenter S, Soza M, Prescott S,   2008;358:125-139.
                      Holland P. Glucocorticoid excess induces preferential depletion
                      of myosin in denervated skeletal muscle fibers. Muscle Nerve.     58. Finfer S, Chittock DR, Su SY, et al. Intensive versus conven-
                      1987;10:428-438.                                       tional glucose control in critically ill patients.  N Engl J Med.
                                                                             2009;360:1283-1297.
                   42. Di Giovanni S, Mirabella M, D’Amico A, Tonali P, Servidei S.
                      Apoptotic features accompany acute quadriplegic myopathy.     59. Stiller K. Physiotherapy in intensive care: an updated systematic
                      Neurology. 2000;55:854-858.                            review. Chest. 2013;144:825-847.
                   43. Batt J, dos Santos CC, Cameron JI, Herridge MS. Intensive care     60. Bailey P, Thomsen GE, Spuhler VJ, et al. Early activity is fea-
                      unit-acquired weakness: clinical phenotypes and molecular   sible and safe in respiratory failure patients.  Crit Care Med.
                      mechanisms. Am J Respir Crit Care Med. 2012;187:238-246.  2007;35:139-145.
                   44. Capasso M, Di Muzio A, Pandolfi A, et al. Possible role for nitric     61. Pohlman MC, Schweickert WD, Pohlman AS, et al. Feasibility
                      oxide dysregulation in critical illness myopathy. Muscle Nerve.   of physical and occupational therapy beginning from initiation
                      2008;37:196-202.                                       of mechanical ventilation. Crit Care Med. 2010;38:2089-2094.
                   45. Rich MM, Pinter MJ, Kraner SD, Barchi RL. Loss of electrical     62. Morris PE, Goad A, Thompson C, et al. Early intensive care unit
                      excitability in an animal model of acute quadriplegic myopathy.   mobility therapy in the treatment of acute respiratory failure.
                      Ann Neurol. 1998;43:171-179.                           Crit Care Med. 2008;36:2238-2243.
                   46. Mozaffar T, Haddad F, Zeng M, Zhang LY, Adams GR,       63. Damluji A, Zanni JM, Mantheiy E, Colantuoni E, Kho ME,
                      Baldwin KM. Molecular and cellular defects of skeletal muscle   Needham DM. Safety and feasibility of femoral catheters during
                      in an animal model of acute quadriplegic  myopathy.  Muscle   physical rehabilitation in the intensive care unit.  J Crit Care.
                      Nerve. 2007;35:55-65.                                  2013;28:535 e9-e15.











            Section06-O-ref.indd   2                                                                                   12/10/2014   6:03:38 PM
   1204   1205   1206   1207   1208   1209   1210   1211   1212   1213   1214